Ricky M. Trigg
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib.
Journal: British journal of haematology
Published: April 20, 2023
Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.
Journal: Nature communications
Published: October 28, 2022
The Contribution of Autophagy and LncRNAs to MYC-Driven Gene Regulatory Networks in Cancers.
Journal: International journal of molecular sciences
Published: June 21, 2021
The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells.
Journal: Cancers
Published: February 09, 2021
Core regulatory circuitries in defining cancer cell identity across the malignant spectrum.
Journal: Open biology
Published: July 08, 2020
Diagnostic accuracy of circulating-free DNA for the determination of MYCN amplification status in advanced-stage neuroblastoma: a systematic review and meta-analysis.
Journal: British journal of cancer
Published: September 08, 2019
Opportunities and challenges of circulating biomarkers in neuroblastoma.
Journal: Open biology
Published: May 16, 2019
The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status.
Journal: Nature communications
Published: February 05, 2019
Early detection of pre-malignant lesions in a KRASG12D-driven mouse lung cancer model by monitoring circulating free DNA.
Journal: Disease models & mechanisms
Published: August 17, 2018
ALK in Neuroblastoma: Biological and Therapeutic Implications.
Journal: Cancers
Published: March 21, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026